Table 1 Characteristics of the included studies
From: Frailty and solid-organ transplant candidates: a scoping review
All | Kidney [14, 19, 20, 25,26,27,28,29,30,31,32,33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48,49,50,51,52,53,54,55,56,57] | Liver [15, 58,59,60,61,62,63,64,65,66,67,68,69,70,71,72,73,74,75,76,77,78,79,80,81,82,83,84,85,86,87,88,89,90,91,92] | Lung [102,103,104,105,106,107,108,109,110,111,112,113,114,115,116,117] | |||
|---|---|---|---|---|---|---|
Studies N (%) | 101 (100.0) | 9 (8.9) | 36 (35.6) | 36 (35.6) | 16 (15.8) | 4 (4.0) |
Publication year N (%) | ||||||
2019–2022 | 63 (62.4) | 6 (66.7) | 22 (61.1) | 24 (66.7) | 8 (50.0) | 3 (75.0) |
2016–2018 | 30 (29.7) | 3 (33.3) | 9 (25) | 10 (27.8) | 7 (43.8) | 1 (25.0) |
2013–2015 | 7 (6.9) | 0 | 4 (11.1) | 2 (5.6) | 1 (6.25) | 0 |
2012 or older | 1 (1.0) | 0 | 1 (2.8) | 0 | 0 | 0 |
Country N (%) | ||||||
USA | 74 (73.3) | 2 (22.2) | 26 (72.2) | 34 (94.4) | 11 (68.8) | 1 (25.0) |
Australia | 9 (8.9) | 5 (55.6) | 0 | 1 (2.8) | 3 (18.8) | 0 |
Japan | 1 (1.0) | 0 | 1 (2.8) | 0 | 0 | 0 |
Italy | 2 (2.0) | 1 (11.1) | 0 | 0 | 0 | 1 (25.0) |
Canada | 2 (2.0) | 0 | 1 (2.8) | 0 | 1 (6.25) | 2 (50.0) |
Poland | 1 (1.0) | 0 | 0 | 0 | 1 (6.25) | 0 |
Netherlands | 2 (2.0) | 0 | 2 (5.6) | 0 | 0 | 0 |
Brazil | 1 (1.0) | 0 | 1 (2.8) | 0 | 0 | 0 |
Spain | 4 (4.0) | 1 (11.1) | 3 (8.3) | 0 | 0 | 0 |
Hong Kong | 1 (1.0) | 0 | 1 | 0 | 0 | 0 |
France | 1 (1.0) | 0 | 1 | 0 | 0 | 0 |
Germany | 1 (1.0) | 0 | 0 | 1 (2.8) | 0 | 0 |
Number of participants | ||||||
# of studies reporting | 101 | 9 | 36 | 36 | 16 | 4 |
Range (N) | 15–125,304 | 37 − 36,790 | 18–125,304 | 50 − 24,505 | 15–618 | 47 − 16,301 |
Age of participants | ||||||
# of studies reporting | 98 | 8 | 34 | 36 | 16 | 4 |
Range (years) | 31.0–64.0 | 51.0–60.0 | 44.7–61.8 | 51.0–64.0 | 31.0-62.9 | 51.2–61.0 |
Median (IQR) | 56.4 (53.1–59.0) | 53.0 (53.0-53.5) | 53.9 (53.0-58.5) | 58.0 (56.4–60.0) | 57.9 (54.8–59.0) | 54.6 (52.6-573.3) |
Percentage of males | ||||||
# of studies reporting | 97 | 8 | 34 | 35 | 16 | 4 |
Range | 42.9–96.1 | 65.0–80.0 | 42.9–96.1 | 54.0-68.8 | 47.7–82.0 | 53.0-80.8 |
Median (IQR) | 60.0 (57.9–66.7) | 70.0 (68.0-74.5) | 62.0 (60.0-63.9) | 59.0 (57.6–64.5) | 56.0 (51.5–58.0) | 64.0 (61.0-68.2) |
Study design N (%) | ||||||
Qualitative | 0 | 0 | 0 | 0 | 0 | 0 |
Experimental | 3 (3.0) | 1(11.1) | 1 (2.8) | 0 | 1 (6.25) | 0 |
Observational | 98 (97.0) | 8 (88.9) | 35 (37.2) | 36 (100.0) | 15 (93.8) | 4 (100.0) |